Patrick Kalona, Director at Phytochemindo Reksa draws a detailed picture of the traditional and herbal medicine industry in Indonesia in addition to presenting the internationalization and growth strategy for the company.
In parallel to your position at Phytochemindo Reksa you are also Chairman of the Indonesian Health Supplement Association (APKSI) and Vice Chairman of the ASEAN Health supplement association (AAHSA). What are the exact activities of APSKI and your main priorities as Chairman?
"We value the alternative medication market at close to USD 1.5 billion, adding USD 700 million for the supplement industry to the 800 million of the traditional medicine industry."
